<?xml version="1.0" encoding="UTF-8"?><BillSummaries>
    <item congress="117" measure-type="s" measure-number="3819" measure-id="id117s3819" originChamber="SENATE" orig-publish-date="2022-03-10" update-date="2022-07-04">
        <title>ARPA–H Act</title>
        <summary summary-id="id117s3819v00" currentChamber="SENATE" update-date="2022-07-04">
            <action-date>2022-03-10</action-date>
            <action-desc>Introduced in Senate</action-desc>
            <summary-text><![CDATA[ <p><strong>Advanced Research Project Authority for Health Act or the ARPA-H Act</strong></p> <p>This bill establishes within the National Institutes of Health (NIH) the Advanced Research Projects Authority for Health to accelerate innovation in health and medicine by investing in high-risk, high-reward research projects. The bill also establishes an interagency advisory committee to inform the authority's activities.</p> <p>The authority director shall be appointed by the President and report to the NIH director. The authority director must, among other duties, designate personnel to serve as program managers who select projects to support, make recommendations about terminating or continuing projects, and otherwise administer authority programs.</p> <p>The authority may use a variety of mechanisms to support the research projects, including grants, contracts, and prize competitions. To receive funding, an applicant must demonstrate sufficient, unsuccessful attempts to secure private funding for its project and other criteria. Furthermore, the authority's budget is separate from the NIH budget. </p> <p>In addition, the authority must (1) develop and periodically update a strategic plan, (2) annually report on its activities, and (3) seek to contract with the National Academies of Sciences, Engineering, and Medicine to evaluate the authority's performance.</p> <p>The Food and Drug Administration (FDA) may meet with the authority and other federal partners to discuss actions to facilitate the development of medical projects and products prioritized by the authority. The authority must reimburse the FDA for the costs associated with supporting authority activities.</p> <p>The bill also requires the Government Accountability Office to report on issues related to the authority's hiring and staffing.</p>]]></summary-text>
        </summary>
    </item>
    <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
        <dc:format>text/xml</dc:format>
        <dc:language>EN</dc:language>
        <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
        <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
        <dc:description>This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
    </dublinCore>
</BillSummaries>
